Melinta Therapeutics announces FDA acceptance of IND for topical radezolid
Melinta Therapeutics announced the FDA has accepted an Investigational New Drug application for topical radezolid for the treatment of mild-to-moderate acne. Melinta and a partner are collaborating on the development of radezolid for treatment of dermatological conditions. February 28, 2017